Company Roglstratlon Numbor: N1605880
Lllac Cancer Support Ltd
(A company Ilmlted by guarantsè, not havino a •hAr• capltsl)
Dlrectors. Report and Unaudited Financial Statements
for the flnancial year ended 31 January 2023

Lilac Cancer Support Ltd
(A company limit•d by guarantve, not havlng a ¥har• ¢apltall
CONTENTS
Pag8
Directors and Other Information
Dir8clors' R8POrt
Accountants. Report
Income and Expendlture Account
Balance Sheet
Notes to the Financial Statements
9-10
Supplementary Information on Income and Expenditure Account
12

Lilac Cancer Support Ltd
IA company Ilmitad by 9uaranleo, not havlng a sharg ¢aplt•ll
DIRECTORS AND OTHER INFORMATION
Dlroctors
Bernadette Morgan
Eamon Morga
Julie ArTrn Mcalisler
Sean Mccloskey {Reslgned 10 October 20221
Ann Walshe
Yvonne Ggrvin
Company R•glstratlon Number
N1605880
Raglsterod Offlce
2nd Floor
Loy Buildings
18 Loy Street
Cookstown
Tyrone
8T80 8PE
Northern Ireland
Bu•lno8• Addr•••
4 Barr8¢k Square
Coallsland
Tyrone
BT714JG
Northern Ireland
Accountant•
O'Hagan, McGllnchey & Co.
Accounlanls
32-34 Dungannon Road
Coallsland
Tyrone
8T714HP
Bankor•
Ulster Bank Llmiled
39 Market Square
Dungannon
Co. Tyrone
8T70 1JJ

Lilac Cancer Support Ltd
(A company limitod by guarant••, not havlng • •h*rg capltsll
DIRECTORS. REPORT
for the financial year ended 31 January 2023
The directors p￿sent their report and the unaudited financlal statements for the financial year ended 31 January
2023.
Prlnclpal Aetlvlty
The company is a cancer charity.
The Company Is Ilmlled by guarantee not havlng a share capltsl.
Flnanclal R•$ults
The surplus for the flnanc181 year after provldlng for depmciallon amounted to £3.00012022 - £2,724).
Dlrectorn
The directors who served during the financi81 year are as follow5..
Bemadelle Morgan
Eamon Morgan
Julie Ann M¢alSster
Sean McClosk8y (Resigned 10 October 20221
Ann Walshe
Yvonne Garvln
There were no changes In shareholdlngs between 31 January 2023 and the dale ol signlng the financlal statements,
In aceordan¢e wllh the Articl•s of Assoclalion, the dSreclors retiro by rolalion and, baing eligible, offer themselves for
ro-election.
Ststomonl ol Dlre¢tors' R••pon8lbllltl••
The dlroclors are responsible for-preparlng the Diig¢lor8' Report and the flnancial 8talemen18 In accordance with
applicable law and regulallons.
Con7pany law requir8$ the directors to prepare financial slalemenls for each Ilnanclal year. Under that law th6
directors have ele￿ed to prepare thè financial statements in accordance with Unitèd Klngdom Generally Accepted
A¢counllng Pracfjce (United Kingdom Accounllng Standards and 8ppIic8ble lawl Including FRS 102 'The Financlal
Roportlng S18ndard applicable in Ihe UK and Republic of Ireland" Section 1A (Small Enlilies). Under company law
the directo￿ musl not approve the financSal slalgmenls unless they are satisfied that they glvo a true and falr view of
the state of affairs of the company Bnd of tho surplus or deficit of tho company for that perlod.
In prepa￿n9 these financlal slalements, the directors are required lo:
801ecl 8uilablo accounllng pollcles and apply them consislenlly,.
make Judgements and accounting 88llmales that are reasonable and prudent.,
prepare the financi81 slalemenls on the going concem basi5 unlèss 11 1$ inappropriate to presume that the
company will continue in business.
Tho directors are responsible for keeping adequate accounting records that ara suffici8nl to show and explaln the
ompanls Iransacllons and dis¢1088 with reasonable aGGuracy at any Ilmg the flnancial position of tho company and
enable them lo ensure that the financlal statements comply with tho Companie$ Act 2006. They are also responsible
for Safeguarding the assets of the company and hence for laklng reasonabl8 steps for the prevention and dglecllon of
fraud and olh&r irregularities.

Lilac Cancer Support Ltd
IA company Ilmited by guaranteg. not havlno a •har• capltall
DIRECTORS. REPORT
for the finan¢ial year ended 31 January 2023
Speelal provlslons relating to small companles
The above report has been prepared in accordance with the $pe¢i81 provisions relating lo small companies within
Part 15 of tha Companies Act 2006.
Onbe
If of the board
Dlr•ctor
ernad8tt0 Morgan
Olrgctor
20 March 2023

Lilac Cancer Support Ltd
IA company limlt•d by guarantee. not havlng a shar• capltalj
ACCOUNTANTS, REPORT
to the Board of Directors on the Compilation of the unaudited financial
statements of Lilac Cancer Support Ltd for the financial year ended 31 January
2023
In accordance with our engagement l&tter and in ordér lo assist you to fulfil your duties under the Companies Act
2006. we have compiled for your approval the financial statements of the company for tho financial year ended 31
January 2023 as set on pages 7 10 10 which comprise the Income and Exp6ndilure Account, the Balance Sheet and
the related notss from the company's aG¢ounting records and from Information and explanations you have given to
us.
Thls réport Is made solgly to the Board of Directors of Lilac Cancer Support Ltd. as a boily, Sn accordance with the
terms of our engag8m&nl. Our work has been undertaken so that we might compllè the flnancial statements that w&
havo been 8ngag8d lo Compile, report lo the company's Board of Directors that we have dong $0, an(1 slate Ihosa
matters that we hav6 ag￿ed to slate to them in this report and for no olhgr purpose. To the fullest exlont pem)illed by
law. we do not accept or assume r85ponsibilily lo anyone other than the Lllac Cancer Support Ltd and its Board of
Olr8Gtors, as a l)ody, for our work or for this r&port.
We have carrled out Ihls engagemènt accordance wllh guldance Issued by accounllng standards and havo
complied with the ¢thic81 guldance laid down by aocounling 8landard$ relallng lo members undertaking th
compilation of finan¢ial 8ta19menls.
You hav8 acknowledged on the balance sheet for the year ended 31 January 2023 your duly lo ensure that Llla
Cancer Support Ltd has kept adequate a¢cotJnling ffjcords and lo prepare slalulory flnanclal slalemenls that give a
true and fair view of tho assets, Ilabllllles, fln8ncial position and surplus of Lilac Cancer Support Ltd. You consider
that Lllac Cancer Support Ltd is exompl fmm thg slalulory audit requirement for the financial year.
We have not been Instructed lo Carry out an audit or a review of the financial statements of Lilac Can¢er Support Ltd
For Ihls rea$on, we have not verlfied the accuracy or completene$5 of the accounllng records or Snformallon and
explanatlons you have glven k) us and we do not, Ihergfore, express any oplnion on the stalulory financial
talomenls.
O'HAGAN, MCGLINCHEY & CO.
Accountants
32-34 Dungannon Road
Co8llsland
Tyrone
BT714HP
23 March 2023

Lilac Cancer Support Ltd
(A cornpany 1Smited by guarantee, not havlng a $har• ¢apltall
INCOME AND EXPENDITURE ACCOUNT
for the financial yaar ended 37 January 2023
2023
Notes
2022
Income
152,192
137,672
Expendhurn
(149,192}
1134.9481
Surpluj for th• flnanelal yoar
Total comprehfjn81vo Incom•
Retained surplus brought foNard
Rotain•d •urplu¥ ¢arrlod forward
3,000
2,724
3.000
2,724
118,762
116,038
121,762
118.762
The notgs on pagtrs 9 to 10 frjrrn part ofthe financial atatements

Lilae Cancer Support Ltd
(A Company Ilmltgd by guarant•¢, not having 41 8h*r• rApltall
Company Règistration Numb•r'. NI005880
BALANCE SHEET
as at 31 January 2023
2023
2022
Notes
Flxéd A8Bets
Tangible assets
20.188
25.417
Curront A880ts
Stocks
Cash and cash equlvalenls
5,500
97,040
5,745
88,300
102.540
94,045
Crodltorn: amounts falllng due wlthln on• y••r
Not Currert Asi•ts
(966)
1700)
101,574
93,345
Total Assots1018 Curront Llabllltl•s
121,762
118,762
Re80rv08
Incomo and expenditure 8c¢ounl
121,762
118.762
Equlty attrlbutabl& to own•r• of th• company
121,702
118,762
The financlal statements have been pr8pared In accordance with the proviÈlon8 appllcable lo companies sublecl to
the sm811 eompanla$' reglme and In a¢¢ordanGe wllh the provlslons of FRS 102 Section IA {Small Enlilias).
For the financial year ended 31 January 2023 the company w88 enlilled to oxemplion from audit und&r secllon 477 of
the Companie8 Act 2006.
The dlrectors confimi that the members have not required the company lo obtaln an audll of 118 financlal ¥lalemen18
for the flnanclal year In quesllon In accordanc8 wllh $ectlon 476 of the Companles ￿t 2006.
Th8 dlr8¢tors acknowledgè Ihair re8ponsibili119s for ensuring that the company keeps accounllng record$ which
comply with section 386 and for preparing finan¢ial slalements whSch give a true and fair view of the slate of affairs of
the company as al the end of the financial year and of ils profil and loss for the finanGial year in a¢cord8n¢e with the
requir8menl$ of seGlion8 394 and 395 and which othe￿ise comply wlth the roquiremenls of the Companies Act 2006
relallng to flnanclal stalemenls. so far a5 applicable to the company.
Appro
by th• 8oard and •ulhorl•od for Is•u• on 20 M•rch 2023 and •lgn•d on It8 behalf by
alsh•
Dlrector
Bgrnadotte Morgan
DireGtor
The notes on pag85 g to 10 form part of the fin8nGial 8tatem¢nt8

Lllac Cancer Support Ltd
NOTES TO THE FINANCIAL STATEMENTS
for the financial year ended 31 January 2023
G•neral Infomiatlon
Lila¢ Cancer Support Ltd is a company limited by guarant89 incorporated in Northern Ireland. 2nd Floor, Loy
Building8. 18 Loy Street, Cookstown, Tyrone, BT80 8PE, Northern Ireland is the registered office, which is
also the princlpal place of busln&s5 of the company. Thè nature of the company's operations and ils principal
acuvilies are sel out in the Dlrectors, Report. The financlal statements have been presented in Pound 1£)
which is also the functional currency of the company.
Summary of Slgnlfl¢ant A¢countlng Pollclos
The following accounting policiés havg bean applied consislenlly In deallng wlth Items which arè consider8d
material in r6lation lo the company's financlal slatgments.
Statsment of compllance
The finan￿81 stslemenls of the company for the year ended 31 January 2023 have been prep8red In
accordance wllh th8 provlgion8 of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
Basls of proparatlon
The financ181 st81emenl$ have been prepargd on the going concèrn b8SIS and In accordance wlth the
hlsloncal cost convention except for certain propertles and financial instrum8nl$ that are measured al
revalued amoun18 or falr valua$, as explalned in the aecounllng policles below. Hlstorical cost Is generally
based on the falr value of the conslderallon glven In exchange for assets.
Incom•
Tumover compdses charlty Shop sal88, donations, fundr8181ng, grants reGeived and olher Gharitable aclivS118S.
Tanglbl• a88ot8 and depreclatlon
Tanglble as$e15 are Staled al cost or at valu8llon, less a¢Gumulated depreclalion. The charge lo deprec1811on
1$ calculated lo W￿te off the ortglnal cost or valuallon of tangible assets. less their &slimatèd resldual value,
over Ih8ir expected usefttl lives as follows..
Plant Bnd machinery
Flxlures, fittings and equipment
Motor vehide8
25% Reducing balancè
25gA Reducing balancg
25°A Reducing balance
The carying values of tangibfe fixed assets are reviewed annually for Impalrmenl in p8rlods if events or
change8 In cirGumslances Indlcale the carying valu6 may nol be recoverable.
8to¢ks
Stocks are valued at the lower of cost and nel realisablo value. Cost comprises expendllure incurred In the
normal course of busingss in bringlng Stocks to their present location and condition.
Full provision is made
for obsolete and slow moving Stems. Net realisable value comprisgs aclual or esllmated selling prlce In6t of
trade dlscounts} less all further costs to completion or lo be incurr8d In markellng and selling.
Tr•do and oth•r ¢r•dltor8
Trade and other Creditors are ini118lly recognised al fair value and thereafter staled at amortised Cost using
the effective interest rale method, unless the effecl of diswunting would be immaterial, in whiGh case they are
8ts1ed at cost.
Taxatlon
Employees
The averag8 monthly number of employees. including dlredors, during the financial year was 4, {2022 - 4).

Lilac Cancer Support Ltd
NOTES TO THE FINANCIAL STATEMENTS
for the flnancial y8ar ènded 31 January 2023
Tangible assets
conkn'nued
Plant and
Flxtures,
machlnery flttlngs and
equlpment
Motor
vehicles
Total
Cost
At 1 Febrnary 2022
Addition8
26,618
1,500
16,945
20,362
63.925
1,500
At 31 January 2023
28.118
16,945
20,362
65,425
D•preclatlon
At 1 February 2022
Charge for th& fi'nancl81 y8ar
At 31 January 2023
9,712
4,601
10.973
1,493
17,823
635
38,508
6.729
14,313
12.466
18.458
45,237
N•1 book value
At 31 January 2023
13,805
4.479
1,904
20.188
At 31 January 2022
16,906
5.972
2,539
25,417
Slock•
2023
2022
Flnl8h8d goods and gt)od8 for resale
5,500
5,745
The repl8¢ement C081 of Stock dld not dlffer $ignifi¢anlly from Ihe flguies shown.
Credltor8
Amount8 falllng du• wlthln on• yoar
Taxation (Note 71
Accru81$
2023
2022
266
700
700
966
700
Taxatlon
2023
2022
Credltors..
PAYE I NI
266
Income 81atement
2023
2022
At 1 February 2022
Surplus for the finandal year
At 31 January 2023
118,762
3,000
116,038
2,724
121.762
118.762
The following reslrlct8d funds (total of £21,000) ar8 included in Reserves al 31101123:
£9,000- Trusthouse. Nationwide, Hallfax
£12,000- Redundancy Reserve
10

LILA
CANCER SUPPORT LTD
IA eompany Ilmlted by guarant•o. not havlng a 8har• caplt•l)
SUPPLEMENTARY INFORMATION
RE
TING TO THE FINANCIAL STA
EME
TS
Fl
11

Lilac Cancer Support Ltd
IA company limit•d by guarantee. not havlng a 6har• capital)
SUPPLEMENTARY INFORMATION RELATING TO THE FINANCIAL STATEMENTS
DETAILED INCOME AND EXPENDITURE ACCOUNT
for the financial year ended 31 January 2023
2023
2022
Income
Shop takings
Grants
Fundraislng & Donations
othor Income
Rental Income
Govemment grant income
78,312
50,993
10,245
11,742
900
32.664
43,802
25,9g3
10,719
1,800
22,694
152.192
137,672
Exp•ndlture
Acllvilies
Flowers, Gifts and Donatlons
Helpar8
Staff pension scheme cost8
Movement in stock
Wages and salari&9
Rent payable
Rat8S
Insurance
Light and heat
Repairs and maintananco
Advertising, stallonery and postage
Telephon8
Motor expenses
Leg81 and piofes$lon81
Accountancy
88nk charges
General oxpens88
Subscrlptions
Depreclallon
18,175
17,557
255
9,604
1,711
{295)
54,628
13.645
557
3,220
2,271
9,171
779
3,139
4,296
2,440
2,349
418
264
467
8,472
12,232
2,332
245
65,303
12,950
677
3.261
3,349
8.671
746
3.075
8,423
792
1,531
148
29
524
6.729
149,192
134,948
N•t •urplu•
3,000
2.724
Thè supplem$ntary information does not form part of the financial statements
12